Kura Oncology (KURA) Interest Coverage Ratio (QoQ) (2010 - 2026)
Kura Oncology (KURA) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Kura Oncology |
883.44 Mn |
883.44 Mn |
18.00 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-141.03% |
| Dec 31, 2025 |
404.73% |
| Sep 30, 2025 |
-11.59% |
| Jun 30, 2025 |
0.74% |
| Mar 31, 2025 |
-306.39% |
| Dec 31, 2024 |
68.20% |
| Sep 30, 2024 |
-5.50% |
| Jun 30, 2024 |
-0.63% |
| Dec 31, 2014 |
90.78% |
| Sep 30, 2014 |
10.16% |
| Jun 30, 2014 |
-25.37% |
| Mar 31, 2014 |
47.73% |
| Dec 31, 2013 |
-80.82% |
| Sep 30, 2013 |
36.27% |
| Jun 30, 2013 |
-12.47% |
| Mar 31, 2013 |
42.40% |
| Dec 31, 2012 |
-77.02% |
| Sep 30, 2012 |
6.32% |
| Jun 30, 2012 |
-4.74% |
| Mar 31, 2012 |
57.31% |
